7 results match your criteria: "King's College Hospital and King's Health Partners[Affiliation]"
J Mol Med (Berl)
February 2020
Translational Molecular Pathology, Vall d'Hebron Institute of Research (VHIR), Universitat Autònoma de Barcelona, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain.
In this review, we highlight the role of intratumoral heterogeneity, focusing on the clinical and biological ramifications this phenomenon poses. Intratumoral heterogeneity arises through complex genetic, epigenetic, and protein modifications that drive phenotypic selection in response to environmental pressures. Functionally, heterogeneity provides tumors with significant adaptability.
View Article and Find Full Text PDFCirculation
January 2018
King's British Heart Foundation Centre, King's College London, United Kingdom (G.S., M.L., J.B.-B., X.Y., U.M., F.B., R.L., M.F., R.H., C.M., C.M.S., M.M.)
Background: Extracellular matrix (ECM) remodeling contributes to in-stent restenosis and thrombosis. Despite its important clinical implications, little is known about ECM changes post-stent implantation.
Methods: Bare-metal and drug-eluting stents were implanted in pig coronary arteries with an overstretch under optical coherence tomography guidance.
Eur Urol
January 2016
Department of Urology Basel, University Hospital Basel, University Basel, Basel, Switzerland. Electronic address:
J Urol
February 2015
Department of Urology, ABMU LHB, Princess of Wales Hospital, Bridgend, Wales. Electronic address:
Purpose: We present the 1-year results of the GOLIATH prospective randomized controlled trial comparing transurethral resection of the prostate to GreenLight XPS for the treatment of men with nonneurogenic lower urinary tract symptoms due to prostate enlargement. The updated results at 1 year show that transurethral resection of the prostate and GreenLight XPS remain equivalent, and confirm the therapeutic durability of both procedures. We also report 1-year followup data from several functional questionnaires (OABq-SF, ICIQ-SF and IIEF-5) and objective assessments.
View Article and Find Full Text PDFEur Urol
May 2014
Department of Urology, ABMU LHB, Princess of Wales Hospital, Bridgend, Wales, UK.
Background: The comparative outcome with GreenLight (GL) photoselective vaporisation of the prostate and transurethral resection of the prostate (TURP) in men with lower urinary tract symptoms due to benign prostatic obstruction (BPO) has been questioned.
Objective: The primary objective of the GOLIATH study was to evaluate the noninferiority of 180-W GL XPS (XPS) to TURP for International Prostate Symptom Score (IPSS) and maximum flow rate (Qmax) at 6 mo and the proportion of patients who were complication free.
Design, Setting, And Participants: Prospective randomised controlled trial at 29 centres in 9 European countries involving 281 patients with BPO.
Heart
September 2013
Cardiovascular Division, King's College Hospital and King's Health Partners, London, UK.
Objective: To investigate the prognostic value of baseline and temporal changes in red cell distribution width (RDW) in patients undergoing transcatheter aortic valve implantation (TAVI).
Design: Single-centre retrospective observational study.
Setting: Tertiary cardiac centre.
Int J Mol Sci
September 2015
Department Histopathology, King's College Hospital and King's Health Partners, Denmark Hill, London SE5 9RS, UK.
Tumor heterogeneity is a confusing finding in the assessment of neoplasms, potentially resulting in inaccurate diagnostic, prognostic and predictive tests. This tumor heterogeneity is not always a random and unpredictable phenomenon, whose knowledge helps designing better tests. The biologic reasons for this intratumoral heterogeneity would then be important to understand both the natural history of neoplasms and the selection of test samples for reliable analysis.
View Article and Find Full Text PDF